Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2018

01-11-2018 | Clinical trial

Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study

Authors: Tara Sanft, Ilana Usiskin, Maura Harrigan, Brenda Cartmel, Lingeng Lu, Fang-Yong Li, Yang Zhou, Anees Chagpar, Leah M. Ferrucci, Lajos Pusztai, Melinda L. Irwin

Published in: Breast Cancer Research and Treatment | Issue 1/2018

Login to get access

Abstract

Purpose

Some studies suggest that telomere shortening may be associated with increased breast cancer risk and mortality. Obesity is also associated with increased breast cancer risk and mortality. Few studies have examined changes in telomere length in overweight or obese breast cancer survivors. The purpose of our study was to examine the effect of a 6-month diet- and exercise-induced weight loss intervention versus usual care on telomere length in breast cancer survivors.

Methods

151 breast cancer survivors with body mass index (BMI) ≥ 25 kg/m2 were randomly assigned to a 6-month weight loss intervention (n = 93) or to usual care (n = 58). Fasting blood samples, height, weight, physical activity, and diet were measured at baseline and 6-months. Relative telomere length (RTL) was measured by quantitative-polymerase chain reaction (qPCR) done on buffy coat-extracted genomic DNA. Mean baseline to 6-month changes were compared between groups (intention-to-treat) using generalized estimating equations.

Results

Complete telomere data were available in 125 participants. Women were 58 ± 8 years, with BMI 33.0 ± 6.2 kg/m2 and were 2.9 ± 2.5 years from diagnosis; 90% were non-Hispanic white, and 76% had stage 0/I breast cancer. After 6 months, women randomized to weight loss had 3% telomere lengthening compared to 5% shortening in the usual care group (p = 0.12). Among women with stage 0/I, the intervention group experienced 7% telomere lengthening compared to 8% shortening in the usual care group (p = 0.01). No intervention effect was observed in women with stage II/III breast cancer.

Conclusion

Our findings suggest a weight loss intervention in stage 0 and 1 breast cancer survivors may lead to telomere lengthening, compared to a shortening in their usual care counterparts.
Literature
1.
go back to reference Lu W, Zhang Y, Liu D et al (2013) Telomeres-structure, function, and regulation. Exp Cell Res 319:133–141CrossRef Lu W, Zhang Y, Liu D et al (2013) Telomeres-structure, function, and regulation. Exp Cell Res 319:133–141CrossRef
2.
go back to reference Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177–208CrossRef Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177–208CrossRef
3.
go back to reference McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331–358CrossRef McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331–358CrossRef
4.
go back to reference Buxton JL, Suderman M, Pappas JJ et al (2014) Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep 4:4954CrossRef Buxton JL, Suderman M, Pappas JJ et al (2014) Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep 4:4954CrossRef
5.
go back to reference Risques RA, Vaughan TL, Li X et al (2007) Leukocyte telomere length predicts cancer risk in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 16:2649–2655CrossRef Risques RA, Vaughan TL, Li X et al (2007) Leukocyte telomere length predicts cancer risk in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 16:2649–2655CrossRef
6.
go back to reference Mirabello L, Garcia-Closas M, Cawthon R et al (2010) Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 21:77–82CrossRef Mirabello L, Garcia-Closas M, Cawthon R et al (2010) Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 21:77–82CrossRef
7.
go back to reference Wentzensen IM, Mirabello L, Pfeiffer RM et al (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1238–1250CrossRef Wentzensen IM, Mirabello L, Pfeiffer RM et al (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1238–1250CrossRef
8.
go back to reference Gramatges MM, Telli ML, Balise R et al (2010) Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 19:605–613CrossRef Gramatges MM, Telli ML, Balise R et al (2010) Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 19:605–613CrossRef
9.
go back to reference De Vivo I, Prescott J, Wong JY et al (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1152–1156CrossRef De Vivo I, Prescott J, Wong JY et al (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1152–1156CrossRef
10.
go back to reference Shen J, Gammon MD, Terry MB et al (2009) Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 124:1637–1643CrossRef Shen J, Gammon MD, Terry MB et al (2009) Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 124:1637–1643CrossRef
11.
go back to reference Shen J, Terry MB, Gurvich I et al (2007) Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538–5544CrossRef Shen J, Terry MB, Gurvich I et al (2007) Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538–5544CrossRef
12.
go back to reference Ma H, Zhou Z, Wei S et al (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 6:e20466CrossRef Ma H, Zhou Z, Wei S et al (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 6:e20466CrossRef
13.
go back to reference Duggan C, Risques R, Alfano C et al (2014) Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst 106:dju035CrossRef Duggan C, Risques R, Alfano C et al (2014) Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst 106:dju035CrossRef
14.
go back to reference Nordfjall K, Eliasson M, Stegmayr B et al (2008) Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 16:2682–2689CrossRef Nordfjall K, Eliasson M, Stegmayr B et al (2008) Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 16:2682–2689CrossRef
15.
go back to reference Kim S, Parks CG, DeRoo LA et al (2009) Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 18:816–820CrossRef Kim S, Parks CG, DeRoo LA et al (2009) Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 18:816–820CrossRef
16.
go back to reference Muezzinler A, Zaineddin AK, Brenner H (2014) Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis. Obes Rev 15:192–201CrossRef Muezzinler A, Zaineddin AK, Brenner H (2014) Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis. Obes Rev 15:192–201CrossRef
17.
go back to reference Cui Y, Gao YT, Cai Q et al (2013) Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women. Obesity (Silver Spring) 21:2582–2588CrossRef Cui Y, Gao YT, Cai Q et al (2013) Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women. Obesity (Silver Spring) 21:2582–2588CrossRef
18.
go back to reference Carulli L, Anzivino C, Baldelli E et al (2016) Telomere length elongation after weight loss intervention in obese adults. Mol Genet Metab 118:138–142CrossRef Carulli L, Anzivino C, Baldelli E et al (2016) Telomere length elongation after weight loss intervention in obese adults. Mol Genet Metab 118:138–142CrossRef
19.
go back to reference Mason C, Risques RA, Xiao L et al (2013) Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21:E549–E554CrossRef Mason C, Risques RA, Xiao L et al (2013) Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21:E549–E554CrossRef
20.
go back to reference Garcia-Calzon S, Moleres A, Marcos A et al (2014) Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON study. PLoS ONE 9:e89828CrossRef Garcia-Calzon S, Moleres A, Marcos A et al (2014) Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON study. PLoS ONE 9:e89828CrossRef
21.
go back to reference Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14:1112–1120CrossRef Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14:1112–1120CrossRef
22.
go back to reference Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34:669–676CrossRef Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34:669–676CrossRef
23.
go back to reference Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21CrossRef Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21CrossRef
24.
go back to reference Lan Q, Cawthon R, Gao Y et al (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 8:e59230CrossRef Lan Q, Cawthon R, Gao Y et al (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 8:e59230CrossRef
25.
go back to reference Ennour-Idrissi K, Maunsell E, Diorio C (2017) Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomarkers Prev 26:3–10CrossRef Ennour-Idrissi K, Maunsell E, Diorio C (2017) Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomarkers Prev 26:3–10CrossRef
26.
go back to reference Zheng YL, Ambrosone C, Byrne C et al (2010) Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 120:769–775CrossRef Zheng YL, Ambrosone C, Byrne C et al (2010) Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 120:769–775CrossRef
27.
go back to reference Zheng YL, Loffredo CA, Shields PG et al (2009) Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 30:1380–1386CrossRef Zheng YL, Loffredo CA, Shields PG et al (2009) Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 30:1380–1386CrossRef
28.
go back to reference Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16:413CrossRef Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16:413CrossRef
29.
go back to reference Cherkas LF, Hunkin JL, Kato BS et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168:154–158CrossRef Cherkas LF, Hunkin JL, Kato BS et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168:154–158CrossRef
Metadata
Title
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study
Authors
Tara Sanft
Ilana Usiskin
Maura Harrigan
Brenda Cartmel
Lingeng Lu
Fang-Yong Li
Yang Zhou
Anees Chagpar
Leah M. Ferrucci
Lajos Pusztai
Melinda L. Irwin
Publication date
01-11-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4895-7

Other articles of this Issue 1/2018

Breast Cancer Research and Treatment 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine